|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0009429,
umls-concept:C0021747,
umls-concept:C0035525,
umls-concept:C0205263,
umls-concept:C0205474,
umls-concept:C0220847,
umls-concept:C0439831,
umls-concept:C0521026,
umls-concept:C0549193,
umls-concept:C0556895,
umls-concept:C0681842,
umls-concept:C0871261,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2911692
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2008-2-26
|
|
pubmed:abstractText |
To analyze whether rapid myelosuppression and a decrease in alanine aminotransferase (ALT) induced by standard interferon (IFN) and ribavirin (RBV) combination therapy predict a sustained viral response (SVR) in hepatitis C virus patients.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-10733558,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-10756359,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-10898329,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-10960463,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-12105843,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-12407599,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-12663245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-14760885,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-16890601,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-17225879,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-3115335,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-7589287,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18299740-9454753
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0835-7900
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
149-52
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18299740-Adult,
pubmed-meshheading:18299740-Alanine Transaminase,
pubmed-meshheading:18299740-Antiviral Agents,
pubmed-meshheading:18299740-Blood Cell Count,
pubmed-meshheading:18299740-Cohort Studies,
pubmed-meshheading:18299740-Drug Therapy, Combination,
pubmed-meshheading:18299740-Female,
pubmed-meshheading:18299740-Hemoglobins,
pubmed-meshheading:18299740-Hepatitis C, Chronic,
pubmed-meshheading:18299740-Humans,
pubmed-meshheading:18299740-Interferons,
pubmed-meshheading:18299740-Male,
pubmed-meshheading:18299740-Middle Aged,
pubmed-meshheading:18299740-Predictive Value of Tests,
pubmed-meshheading:18299740-Retrospective Studies,
pubmed-meshheading:18299740-Ribavirin,
pubmed-meshheading:18299740-Time Factors,
pubmed-meshheading:18299740-Treatment Outcome,
pubmed-meshheading:18299740-Viral Load
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Does a rapid decline in the hematological and biochemical parameters induced by interferon and ribavirin combination therapy for the hepatitis C virus predict a sustained viral response?
|
|
pubmed:affiliation |
McGill University Health Centre, Montreal, Canada.
|
|
pubmed:publicationType |
Journal Article
|
